Beata Juzyna

Unicancer R&d
Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Assessing and comparing patient engagement in clinical cancer research: A cross-regional analysis between Europe and Japan using a structured evaluation tool.

Assessing and comparing patient engagement in clinical cancer research: A cross-regional analysis between Europe and Japan using a structured evaluation tool.

Journal: Journal of cancer policy

Published: April 24, 2025

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 21, 2024

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 17, 2023

Flexible modeling of longitudinal health-related quality of life data accounting for informative dropout in a cancer clinical trial.

Flexible modeling of longitudinal health-related quality of life data accounting for informative dropout in a cancer clinical trial.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: September 01, 2022

Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial.

Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial.

Journal: Cancers

Published: August 30, 2022

When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.

When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.

Journal: BMC medical research methodology

Published: June 22, 2022

Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.

Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.

Journal: The oncologist

Published: April 13, 2022

Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials.

Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: November 13, 2021

Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans.

Gemcitabine plus nab-paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans.

Journal: Seminars in oncology

Published: February 02, 2021

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: November 23, 2020

Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.

Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: August 06, 2020

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.

Journal: BMC medical research methodology

Published: May 27, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026